Matthew Frank Paul Calabrese

Title: Matthew Frank Paul Calabrese: Innovator in AMPK Activation Compounds

Introduction

Matthew Frank Paul Calabrese is a notable inventor based in Old Lyme, Connecticut. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that activate AMP-activated protein kinase (AMPK). His work is crucial for advancing therapeutic strategies in various metabolic disorders.

Latest Patents

Calabrese holds a patent for "Compounds for the activation of AMPK." This patent describes innovative compounds of Formula I that have potential applications in enhancing metabolic health. His research in this area is paving the way for new treatments that could benefit many individuals suffering from metabolic diseases.

Career Highlights

Calabrese is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer allows him to collaborate with some of the brightest minds in the industry, contributing to groundbreaking research and development.

Collaborations

Throughout his career, Calabrese has worked alongside esteemed colleagues such as Gary Erik Aspnes and Christopher Ryan Butler. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their shared field of research.

Conclusion

Matthew Frank Paul Calabrese is a distinguished inventor whose work on AMPK activation compounds is making a meaningful impact in the pharmaceutical industry. His contributions, along with his collaborations, highlight the importance of innovation in addressing metabolic health challenges.